These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7645972)

  • 1. Addition of hTNF alpha potentiates cytotoxicity of taxol in human ovarian cancer lines.
    Berkova N; Pagé M
    Anticancer Res; 1995; 15(3):863-6. PubMed ID: 7645972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A; Buckman R; Kerbel RS
    Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
    Safrit JT; Berek JS; Bonavida B
    Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
    Morimoto H; Safrit JT; Bonavida B
    J Immunol; 1991 Oct; 147(8):2609-16. PubMed ID: 1918981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.
    Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M
    Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
    George JA; Chen T; Taylor CC
    Cancer Res; 2005 Nov; 65(22):10381-8. PubMed ID: 16288028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
    Brader KR; Wolf JK; Hung MC; Yu D; Crispens MA; van Golen KL; Price JE
    Clin Cancer Res; 1997 Nov; 3(11):2017-24. PubMed ID: 9815592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD].
    Cheng G; Tian F; Li Y
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol and radiation.
    Geard CR; Jones JM; Schiff PB
    J Natl Cancer Inst Monogr; 1993; (15):89-94. PubMed ID: 7912535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human TNF on human ovarian cancer cell lines.
    Vigani A; Miglietta L; Chiara S; Repetto L; Pichi E; Cimoli G; Morelli L; Poggi L; Billi G; Parodi S
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):537-42. PubMed ID: 2257120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D; Siré EG; De Feudis P; Vikhanskaya F; Valenti M; Russo P; Parodi S; D'Incalci M; Broggini M
    Cancer Res; 1997 Mar; 57(5):870-4. PubMed ID: 9041188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3].
    Tong Y; Pan L; Zhou S
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):677-9. PubMed ID: 11218898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell line and schedule-dependent cytotoxicity of paclitaxel (Taxol): role of the solvent Cremophor EL/ethanol.
    Cordes N; Plasswilm L
    Anticancer Res; 1998; 18(3A):1851-7. PubMed ID: 9673415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer.
    Alakhov VYu ; Moskaleva EYu ; Batrakova EV; Kabanov AV
    Bioconjug Chem; 1996; 7(2):209-16. PubMed ID: 8983343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
    Michalakis J; Georgatos SD; Romanos J; Koutala H; Georgoulias V; Tsiftsis D; Theodoropoulos PA
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):615-22. PubMed ID: 16025289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol sensitizes human ovarian cancer cells to radiation.
    Steren A; Sevin BU; Perras J; Angioli R; Nguyen H; Guerra L; Koechli O; Averette HE
    Gynecol Oncol; 1993 Feb; 48(2):252-8. PubMed ID: 8094062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.